SUPRIYA Supriya Lifescience Ltd Expansion Plans Announcement 2024 - Approval of Capital Expenditure Supriya Lifescience Ltd has received approval for a capital expenditure of Rs. 60 crores over the next 3 years for the development of a CDMO facility at their Ambernath site..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Supriya Lifescience Ltd